Paumelle Rejane, Tulasne David, Kherrouche Zoulika, Plaza Serge, Leroy Catherine, Reveneau Sylvie, Vandenbunder Bernard, Fafeur Veronique
CNRS FRE 2353, Institut de Biologie de Lille, Institut Pasteur de Lille, B.P.447, 59021 Lille, France.
Oncogene. 2002 Apr 4;21(15):2309-19. doi: 10.1038/sj.onc.1205297.
Hepatocyte growth factor/scatter factor (HGF/SF) induces scattering and morphogenesis of epithelial cells through the activation of the MET tyrosine kinase receptor. Although the activated MET receptor recruits a number of signaling proteins, little is known of the downstream signaling pathways activated by HGF/SF. In this study, we wished to examine the signaling pathway leading to activation of the ETS1 transcription factor. Using in vitro and in vivo kinase assays, we found that HGF/SF activates the ERK1 MAP kinase, leading to the phosphorylation of the threonine 38 residue of ETS1 within a putative MAP kinase phosphorylation site (PLLT38P). This threonine residue was neither phosphorylated by JNK1, nor by p38 MAP kinases and was required for the induction of transcriptional activity of ETS1 by HGF/SF. Using kinase and transcription assays, we further demonstrated that phosphorylation and activation of ETS1 occurs downstream of a RAS-RAF-MEK-ERK pathway. The functional involvement of this pathway in HGF/SF action was demonstrated using U0126, a pharmacological inhibitor of MEK, which blocked phosphorylation and activation of ETS1, RAS-dependent transcriptional responses, cell scattering and morphogenesis. These data demonstrated that ETS1 is a downstream target of HGF/SF acting through a RAS-RAF-MEK-ERK pathway and provides a signaling pathway leading to the regulation of gene expression by HGF/SF.
肝细胞生长因子/分散因子(HGF/SF)通过激活MET酪氨酸激酶受体诱导上皮细胞的分散和形态发生。尽管活化的MET受体募集了许多信号蛋白,但对于HGF/SF激活的下游信号通路却知之甚少。在本研究中,我们希望研究导致ETS1转录因子激活的信号通路。通过体外和体内激酶测定,我们发现HGF/SF激活ERK1丝裂原活化蛋白激酶(MAP激酶),导致ETS1的苏氨酸38残基在一个假定的MAP激酶磷酸化位点(PLLT38P)内发生磷酸化。该苏氨酸残基既不被JNK1磷酸化,也不被p38 MAP激酶磷酸化,并且是HGF/SF诱导ETS1转录活性所必需的。通过激酶和转录测定,我们进一步证明ETS1的磷酸化和激活发生在RAS-RAF-MEK-ERK通路的下游。使用MEK的药理学抑制剂U0126证明了该通路在HGF/SF作用中的功能参与,它阻断了ETS1的磷酸化和激活、RAS依赖性转录反应、细胞分散和形态发生。这些数据表明ETS1是HGF/SF通过RAS-RAF-MEK-ERK通路作用的下游靶点,并提供了一条导致HGF/SF调节基因表达的信号通路。